Exicure (XCUR) Other financing activities (2018 - 2022)

Exicure (XCUR) reported Other financing activities of $506000.0 for Q1 2022, up 216.25% quarter-over-quarter from $160000.0 in Q4 2020.

Exicure (XCUR) Other financing activities (2018 - 2022) Analysis & Trends

Exicure has reported Other financing activities for 4 years, with the latest figure at $506000.0 in Q1 2022.

  • For the quarter ending Q1 2022, Other financing activities changed N/A year-over-year to $506000.0; the trailing twelve-month figure through Dec 2022 stood at $506000.0 (changed N/A YoY), and the FY2022 full-year result was $506000.0, changed N/A from the prior year.
  • Other financing activities for Q1 2022 stood at $506000.0, up from $160000.0 in the prior quarter.
  • The five-year high for Other financing activities was $506000.0 in Q1 2022, with the low at -$1000.0 in Q4 2019.
  • Historically, Other financing activities has averaged $164875.0 across 4 years, with a median of $130000.0 in 2020.
  • Annual changes were most pronounced in 2019 — Other financing activities slumped 103.85% — and 2020, when it jumped 16100.0%.
  • Exicure's Other financing activities stood at $26000.0 in 2018, then slumped by 103.85% to -$1000.0 in 2019, then jumped by 16100.0% to $160000.0 in 2020, then surged by 216.25% to $506000.0 in 2022.
  • The last three Other financing activities figures came in at $506000.0 (Q1 2022), $160000.0 (Q4 2020), and $244000.0 (Q3 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn -
7 Psyence Biomedical 251.43 Bn 251.42 Bn -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn
9 Abivax 94.37 Bn 94.37 Bn -
10 Exicure 19.38 Mn 16.77 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2022 506,000.00
Mar 31, 2022 506,000.00
Dec 31, 2020 160,000.00
Dec 31, 2020 160,000.00
Sep 30, 2020 244,000.00
Sep 30, 2020 244,000.00
Mar 31, 2020 100,000.00
Mar 31, 2020 100,000.00
Dec 31, 2019 -1,000.00
Dec 31, 2019 -1,000.00
Sep 30, 2019 232,000.00
Sep 30, 2019 232,000.00
Mar 31, 2019 52,000.00
Mar 31, 2019 52,000.00
Dec 31, 2018 26,000.00
Dec 31, 2018 26,000.00